AGC Biologics stands out as a global leader in the biopharmaceutical Contract Development and Manufacturing Organization (CDMO) sector, offering specialized services for the scale-up and cGMP manufacture of protein-based therapeutics and other complex biologics. The company's proprietary CHEF1™ Expression System for efficient protein production, coupled with its commitment to delivering reliable and compliant drug substances, underscores its technical prowess and competitive edge. With cGMP-compliant facilities across the US, Europe, and Japan, AGC Biologics not only ensures global reach but also fosters strong partnerships with customers, aiding them in accelerating their projects and managing product lifecycle costs.